In conversation with...

Predicting the added benefit of adjuvant chemotherapy

February 19, 2020 The Lancet
In conversation with...
Predicting the added benefit of adjuvant chemotherapy
Show Notes

Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.